Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)

1 Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation Stroke, May 29, 2013

2 Apixaban: a new factor xa inhibitor for stroke prevention in patients with nonvalvular atrial fibrillation Cardiology in Review, June 7, 2013

3 Atrial fibrillation as a risk factor for cognitive impairment: A semi-systematic review QJM: An International Journal of Medicine, June 13, 2013    Evidence Based Medicine

4 Insulin resistance and risk of incident heart failure Circulation: Heart Failure, June 10, 2013

5 Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation Circulation, June 4, 2013

6 Atrial fibrillation in CKD: Balancing the risks and benefits of anticoagulation American Journal of Kidney Diseases, June 11, 2013

7 Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation Journal of Interventional Cardiac Electrophysiology , June 11, 2013

8 Atrial fibrillation in young stroke patients European Journal of Neurology, May 22, 2013

9 Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation EP Europace, May 29, 2013

10 Factors associated with length of hospitalization in patients admitted with transient ischemic attack in United States Stroke, May 30, 2013